Press Releases

CIRM-funded research programs are helping turn stem cells into cures. Browse our press release archive below to find out the latest advances. For even more breaking news, visit our blog, The Stem Cellar.

Aug 7, 2020
Dean of UC Davis School of Medicine Joins Stem Cell Agency Board
Jul 24, 2020
CIRM Board Approves Two New Discovery Research Projects for COVID-19
Jul 10, 2020
CIRM Board Approves Two Discovery Research Projects for COVID-19
Jun 26, 2020
CIRM Board Approves Third Clinical Trial for COVID-19
Jun 12, 2020
CIRM Board Approves Two Additional COVID-19 Projects
May 29, 2020
Stem Cell Agency Board Approves Three More Projects Targeting COVID-19
May 22, 2020
CIRM Board Expands Efforts of COVID-19 Program
May 15, 2020
CIRM Board Approves Clinical Trials Targeting COVID-19 and Sickle Cell Disease
Apr 24, 2020
CIRM Board Funds its First Clinical Study for COVID-19
Apr 10, 2020
CIRM Board Expands COVID-19 Efforts
Mar 27, 2020
Stem Cell Agency Board Approves $5 Million in Emergency Funding for COVID-19 Research
Dec 16, 2019
Journalism Pioneer and Founder of Latino Cancer Institute Joins Stem Cell Agency Board
Dec 13, 2019
CIRM’s Alpha Stem Cell Clinics Given High Profile Role in Clinical Trials Network
Oct 31, 2019
Stem Cell Agency Approves Funding for Clinical Trials Targeting Parkinson’s Disease and Blindness
Oct 9, 2019
New Report Says Stem Cell Agency Produces Measurable Economic Benefits for California
Jul 24, 2019
CIRM Board Approves New Clinical Trial for Breast Cancer Related Brain Metastases
Jun 20, 2019
CIRM Board Approves New Clinical Trial for Rare Childhood Disease
May 23, 2019
Stem Cell Agency Board Approves New Clinical Trial for Type 1 Diabetes
May 1, 2019
CIRM Board Approves Funding for New Clinical Trials in Solid Tumors and Pediatric Disease
Apr 30, 2019
CIRM & NHLBI Create Landmark Agreement on Curing Sickle Cell Disease
Mar 21, 2019
Stem Cell Agency Awards Almost $4 Million to Develop a Treatment for Spinal Degeneration
Feb 21, 2019
Stem Cell Agency Invests in Chemotherapy-Free Approach to Rare But Deadly Childhood Disease
Jan 30, 2019
Rare Disease Gets Big Boost from California’s Stem Cell Agency
Dec 13, 2018
Stem Cell Agency Board Approves 50th Clinical Trial
Nov 15, 2018
Promising Approach to Curing Spina Bifida Gets $5.6 Million from Stem Cell Agency
Oct 18, 2018
Stem Cell Agency Invests in New Immunotherapy Approach to HIV, Plus Promising Projects Targeting Blindness and Leukemia
Jul 19, 2018
Late-Stage Preclinical Research Targeting Prostate Cancer Gets Almost $4 Million Support from California’s Stem Cell Agency
Jun 28, 2018
California’s Stem Cell Agency Invests in Research Developing New Treatments for Parkinson’s and Brain Tumors
Jun 25, 2018
U.C. Irvine’s Suzanne Sandmeyer joins Board of Stem Cell Agency
May 24, 2018
Clinical Trial Targeting Lung Cancer, Plus Promising Osteoporosis and Incontinence Research get Support from Stem Cell Agency
May 10, 2018
California’s Stem Cell Agency Applauds FDA for Crackdown on Stem Cell Clinics that “Peddle Unapproved Treatments.”
May 7, 2018
California’s Stem Cell Agency Supports Orchard Therapeutics’ Acquisition of GSK Gene Therapy Programs for Rare Diseases
Apr 27, 2018
Therapies Targeting Cancer, Deadly Immune Disorder and Life-Threatening Blood Condition Get Almost $32 Million Boost from Stem Cell Agency
Apr 26, 2018
CIRM President/CEO Presenting at Vatican Conference Targeting Cures for Deadly Diseases
Apr 5, 2018
CIRM Launches Industry Alliance Program to Facilitate Partnerships That Advance Stem Cell Therapies
Apr 4, 2018
Stem Cell Agency-Funded Clinical Trial for Age-Related Macular Degeneration Shows Encouraging Results
Feb 22, 2018
California's Stem Cell Agency Invests in Stem Cell-Based Therapies Targeting Sickle Cell Disease and Cancer
Jan 18, 2018
California’s Stem Cell Agency Invests in Phase 3 Clinical Trial to Help Kidney Transplant Patients
Jan 17, 2018
Tireless Patient Advocate for California’s Stem Cell Agency to be Honored at World Stem Cell Summit
Dec 14, 2017
Research Targeting Diabetes, Liver Failure and HIV Get Support from California Stem Cell Agency
Nov 30, 2017
California Stem Cell Agency Invests $16.4 Million to Test Great New Ideas Targeting Cancer, Vision Loss and Parkinson’s Disease.
Oct 26, 2017
Clinical Trials for Osteoarthritis, Multiple Myeloma and Making Bone Marrow Transplants Safer Get Go-ahead from Stem Cell Agency Board.
Oct 2, 2017
Asterias Biotherapeutics announces positive 12-month results for CIRM-funded spinal cord injury trial
Sep 28, 2017
California Stem Cell Agency Appoints New President and Invests in Additional Alpha Clinics and Clinical Trials Targeting Cancer, Diabetes and Kidney Disease
Sep 19, 2017
Biotech CEO David W. Martin Joins Stem Cell Agency Board
Sep 11, 2017
UCLA Launches CIRM-Funded Cancer Clinical Trial
Aug 24, 2017
Stem Cell Agency Invests in Clinical Trial that Uses a One-Two Punch to Confuse and Kill Leukemia Cells
Jul 20, 2017
Phase 3 Clinical Trial Targeting Lou Gehrig's Disease Gets $15.9 Million Investment From Stem Cell Agency
Jun 29, 2017
Stem Cell Agency invests more than $44 million in treatments for stroke and fixing blood disorders in the womb
Jun 12, 2017
Baseball’s Loss is Stem Cell Agency’s Gain as Stanford’s Linda Boxer Appointed to CIRM Board

Pages

Media Contact

Koren Temple-Perry
Senior Director of Marketing & Communications
510-775-2314
ktemple-perry@cirm.ca.gov